Cetera Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-19,759
Closed -$367K 1865
2023
Q3
$367K Sell
19,759
-422
-2% -$9.85K 0.01% 1219
2023
Q2
$511K Sell
20,181
-252
-1% -$6.34K 0.01% 1044
2023
Q1
$529K Buy
+20,433
New +$547K 0.01% 989
2022
Q1
Sell
-4,493
Closed -$413K 1526
2021
Q4
$413K Buy
4,493
+1,515
+51% +$181K 0.01% 968
2021
Q3
$378K Buy
2,978
+436
+17% +$63.5K 0.01% 995
2021
Q2
$423K Sell
2,542
-841
-25% -$136K 0.01% 901
2021
Q1
$615K Buy
3,383
+2,100
+164% +$487K 0.02% 658
2020
Q4
$257K Buy
1,283
+31
+2% +$6.3K 0.01% 883
2020
Q3
$274K Sell
1,252
-383
-23% -$81.1K 0.01% 765
2020
Q2
$312K Sell
1,635
-6,859
-81% -$1.2M 0.01% 690
2020
Q1
$1.32M Buy
+8,494
New +$988K 0.07% 275

Other funds holding TDOC

Cetera Advisors's TDOC Position: Q4 2023 in Review

Cetera Advisors sold out of Teladoc Health (TDOC) in Q4 2023, closing a stake of 19,759 shares — an estimated $367K sold.

Cetera Advisors first reported a position in TDOC in Q1 2020 and held it in 11 quarters. The position peaked at $1.32M in Q1 2020. 435 funds tracked by Wall St. Rank hold TDOC as of Q4 2023.

  • Cetera Advisors reported no remaining Teladoc Health position as of Q4 2023 after selling out during the quarter.
  • Cetera Advisors sold 19,759 Teladoc Health shares in Q4 2023, an estimated $367K.
  • Cetera Advisors first reported a position in Teladoc Health in Q1 2020 and held it in 11 quarters.
  • Cetera Advisors's Teladoc Health position peaked at $1.32M in Q1 2020.
  • 435 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2023.

Based on Cetera Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.